Abstract
Cinnoline is a potential pharmacophore which has rarely been reported for uses as PI3K inhibitors. In this study, a series of cinnoline derivatives were developed as PI3K inhibitors and evaluated for enzymatic and cellular activities. Most compounds displayed nanomolar inhibitory activities against PI3Ks, among which 25 displayed high LLE and micromolar inhibitory potency against three human tumor cell lines (IC50 = 0.264 μM, 2.04 μM, 1.14 μM).
Keywords:
Cinnoline; PI3K inhibitor; PI3K/Akt pathway.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Dose-Response Relationship, Drug
-
Drug Discovery*
-
Drug Screening Assays, Antitumor
-
Heterocyclic Compounds, 2-Ring / chemical synthesis
-
Heterocyclic Compounds, 2-Ring / chemistry
-
Heterocyclic Compounds, 2-Ring / pharmacology*
-
Humans
-
Molecular Structure
-
Phosphatidylinositol 3-Kinases / metabolism*
-
Phosphoinositide-3 Kinase Inhibitors / chemical synthesis
-
Phosphoinositide-3 Kinase Inhibitors / chemistry
-
Phosphoinositide-3 Kinase Inhibitors / pharmacology*
-
Structure-Activity Relationship
Substances
-
Antineoplastic Agents
-
Heterocyclic Compounds, 2-Ring
-
Phosphoinositide-3 Kinase Inhibitors
-
cinnoline